Drug hapten-specific T-cell activation: Current status and unanswered questions. (2021)
Attributed to:
Development of a stepwise screening approach to assess the intrinsic immunogenicity of drugs and chemicals
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/pmic.202000267
PubMed Identifier: 33651918
Publication URI: http://europepmc.org/abstract/MED/33651918
Type: Journal Article/Review
Volume: 21
Parent Publication: Proteomics
Issue: 17-18
ISSN: 1615-9853